Prospective Database for Acute Myeloblastic Leukemia

Leukemia, Myeloblastic, Acute Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00538278
• Other study ID #: RAC #2051-057
• Status: Active, not recruiting
• Phase: N/A
• First received: October 1, 2007
• Last updated: December 11, 2011
• Start date: October 2007
• Est. completion date: October 2020

Study information

• Verified date: December 2011
• Source: King Faisal Specialist Hospital & Research Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Prospective Database for Acute Myeloblastic Leukemia

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 2000
• Est. completion date: October 2020
• Est. primary completion date: October 2020
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with AML

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Leukemia, Myeloblastic, Acute
• Leukemia, Myeloid, Acute

Intervention

Other:
• Database
database

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
King Faisal Specialist Hospital & Research Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	safety and efficacy		10 years	No